Conrad Wang is listed as a director on 11 SEC Form D filings by 3 issuers between Mar 2010 and Oct 2025: AcuFocus, Inc. (Irvine, CA — biotechnology — 2016–2018; $74.9M reported sold to 23 investors), Eyconis, Inc. (Redwood City, CA — industry reported as "Other" — 2024–2025; $60.3M reported sold to 7 investors) and ACCESS CLOSURE, INC. (Mountain View, CA — industry reported as "Other" — 2010–2013; $10M reported sold to 69 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 15 years. Across those companies the filings report $145.2M sold in total.
Listed alongside Farhad Khosravi (7 shared filings), Hank Plain (7 shared filings), JEFFREY LIGHTCAP (7 shared filings), Jeani Delagardelle (7 shared filings), Jeff Gold (7 shared filings) and 27 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Conrad. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 11 public filings for Conrad Wang and found 6 differences: Form D filed 55 days after the first sale; 4 offerings changed their target amount between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.